Tools

LEADER 02442cam a2200469Ka 4500

001 ocm54912019;

003 OCoLC;

005 20040426115729.0;

006 m d f ;

008 040408s2003 mdu o f000 0 eng d;

040 a| GPOc| GPOd| MvI;

049 a| ERE#;

074 a| 0491-B-31 (online);

086 0 a| HE 20.6524:76/V.1-2;

245 00 a| Ephedra and ephedrine for weight loss and athletic performance enhancement :b| clinical efficacy and side effects /c| prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Southern California Evidence-Based Practice Center, RAND ; Paul Shekelle ... [et al.].;

260 a| [Rockville, Md. :b| Agency for Healthcare Research and Quality,c| 2003];

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

490 1 a| Evidence report/technology assessment,x| 1530-440X ;v| no. 76;

490 1 a| AHRQ publication ;v| no. 03-E 022;

538 a| Mode of access: Internet from the AHRQ web site. Address as of 4/26/04: http://www.ahrq.gov/downloads/pub/evidence/pdf/ephedra/contents.pdf; current access available via PURL.;

500 a| Title from title screen (viewed on Apr. 8, 2004).;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

505 0 a| v. 1. Evidence report and evidence tables -- v. 2. Appendixes.;

650 0 a| Ephedrinex| Physiological effect.=| ^A575061;

650 0 a| Ephedrax| Physiological effect.=| ^A854181;

650 0 a| Ephedrinex| Toxicology.=| ^A575061;

650 0 a| Ephedrax| Toxicology.=| ^A854181;

650 0 a| Appetite depressants.=| ^A13562;

650 0 a| Doping in sports.=| ^A92326;

700 1 a| Shekelle, Paul G.=| ^A577741;

710 1 a| United States.b| Agency for Healthcare Research and Quality.=| ^A457038;

710 2 a| Southern California Evidence-Based Practice Center/RAND.=| ^A570416;

776 1 t| Ephedra and ephedrine for weight loss and athletic performance enhancementh| 2 v.w| (DLC) 2003426075w| (OCoLC)51873272;

830 0 a| Evidence report/technology assessmentv| no. 76.=| ^A480454;

830 0 a| AHRQ publication ;v| no. 03-E 022.=| ^A457037;

856 40 u| https://purl.fdlp.gov/GPO/LPS47169;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 959094;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| MQ1693160d| 8/7/2007l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 5/12/2004x| EDOCUMENTz| JERESOURCEo| .STAFF. 0;

Ephedra and ephedrine for weight loss and athletic performance enhancement : clinical efficacy and side effects / prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Southern California Evidence-Based Practice Center, RAND ; Paul Shekelle ... [et al.].

Other author	Shekelle, Paul G.
Other author	United States. Agency for Healthcare Research and Quality.
Other author	Southern California Evidence-Based Practice Center/RAND.
Format	Electronic
Publication Info	[Rockville, Md. : Agency for Healthcare Research and Quality, 2003]
Supplemental Content	https://purl.fdlp.gov/GPO/LPS47169
Subjects	Ephedrine--Physiological effect. Ephedra--Physiological effect. Ephedrine--Toxicology. Ephedra--Toxicology. Appetite depressants. Doping in sports.

Series	Evidence report/technology assessment, 1530-440X ; no. 76 AHRQ publication ; no. 03-E 022 Evidence report/technology assessment no. 76. ^A480454 AHRQ publication ; no. 03-E 022. ^A457037
Contents	v. 1. Evidence report and evidence tables -- v. 2. Appendixes.
General note	Title from title screen (viewed on Apr. 8, 2004).
General note	GPO Cataloging Record Distribution Program (CRDP).
Technical details	Mode of access: Internet from the AHRQ web site. Address as of 4/26/04: http://www.ahrq.gov/downloads/pub/evidence/pdf/ephedra/contents.pdf; current access available via PURL.
GPO item number	0491-B-31 (online)
Govt. docs number	HE 20.6524:76/V.1-2

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Click here for more information about this title

Availability